A Study of Diroximel Fumarate (DRF) in Adult Participants From the Asia-Pacific Region With Relapsing Forms of Multiple Sclerosis (RMS)
Clinical trial NCT05083923 · COMPLETED
Trial details
- NCT number
- NCT05083923
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-18
- Primary completion
- 2024-09-11
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.